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eHealth andmHealth interventions for type 2 diabetes are emerging as useful strategies to accomplish the goal of a high functioning
integrated care system. However, mHealth and eHealth interventions in order to be successful need the clear endorsement from the
healthcare professionals. This cross-sectional study included a sample of 93 Italian-speaking type 2 diabetes patients and demon-
strated the role of the perceived ability of healthcare professionals to motivate patients’ initiative in improving the level of their
engagement and activation in type 2 diabetes self-management.The level of type 2 diabetes patients’ activation resulted also in being
a direct precursor of their attitude to the use of mHealth and eHealth. Furthermore, patient engagement has been demonstrated
to be a mediator of the relationship between the perceived ability of healthcare professionals in motivating type 2 diabetes patients
and patients’ activation. Finally, type 2 diabetes patients adherence did not result in being a direct consequence of the frequency of
mHealth and eHealth use. Patient adherence appeared to be directly influenced by the level of perceived healthcare professionals
ability of motivating patients’ autonomy. These results offer important insights into the psychosocial and organizational elements
that impact on type 2 diabetes patients’ activation in self-management and on their willingness to usemHealth and eHealth devices.
1. Introduction
Diabetes currently constitutes a large and growing clinical
problem, and its costs for society are high and are escalating.
Worldwide, estimated 387 million adults are living with dia-
betes, and this number is projected to increase to 592 million
by 2035 [1–3]. Effective prevention strategies are, therefore,
crucial to slow the diabetes tide and its burden. Nearly 9 out
of 10 new diabetes cases are type 2 diabetes, characterized
by a gradual increase in glycemia [1]; obesity and physical
inactivity are some of the most common risk factors [2].
Since type 2 diabetes requires long-term treatment, over
the past 20 years the responsibility for the care of people
affected by this condition has shifted away from hospitals to
primary care settings.The long-termmanagement of chronic
conditions requires a revision of classical models of care in
order to guarantee positive care outcomes [4] and enhance
patient’s quality of life [5]. To address this requirement and to
manage the patients’ care, a more effective synergy between
healthcare organizations and territorial services is required
[6–8]. Chronic conditions, such as type 2 diabetes, need long-
term approach to care, which imply a higher synergy and
service integration “outside” of the institutional boundaries
of hospitals [9–11].Thus healthcare organizations not only are
concernedwith the long-termmanagement of type 2 diabetes
patient but also are claimed to redesign their organizational
models in accordance with local resources and demands of
care. This requires a better integration with the resources
(formal and informal; expert and lay) that are present in the
territories [12, 13].
Integrated care organizationalmodels are currently envis-
aged as the potential solution to improve quality and
sustainability of healthcare services, particularly when the
management of chronic condition (such as type 2 diabetes)
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is concerned. However, to achieve the goal of an integrated
system of care, the role of the patient, as main actor of
such a process, needs to be questioned [14]. In order to
guarantee the fruitful collaboration and dialogue between
the lay territory of reference for the patient and his/her
reference healthcare provider, type 2 diabetes patients need
to be helped in enacting an active and cocreative role along
their process of care, moving from the traditional passive
position of recipients of care to the one of the real engaged
consumers in the design and delivery of healthcare services
[15–18]. Type 2 diabetes patients’ engagement is regarded as
a key factor to improve the quality and the sustainability of
healthcare services [15, 17, 19]. Previous studies have shown
how an engaged patient is more likely keen to act improved
health behaviors [20], to have better clinical outcomes [21],
to perceive a better quality of life [22], and to be more
satisfied with their relationship with the healthcare system
[23]. Furthermore, empirical researches have demonstrated
how patient engagement may contribute to a reduction
of healthcare costs and to better economically sustainable
organizational processes [24, 25].
In such a frame, eHealth and mHealth interventions are
emerging as a useful strategy to accomplish the goal of a
better integrated system of care [11, 26, 27]. As technology-
based interventions are becoming regular part of the health
care environment, viewing these tools in light of the skills
(knowledge and behaviors) required for patients to success-
fully use them becomes essential if the power of eHealth
and mHealth is to be leveraged to deliver health care effec-
tively. As a consequence, promoting patient’s eHealth literacy,
defined as the ability to seek, find, understand, and appraise
health information from electronic sources and apply the
knowledge gained to addressing or solving a health problem
[28], becomes a priority to enhance the continuity of care.
Indeed, eHealth and mHealth offer continuous monitoring
of clinical parameters, allowing the “on-demand” commu-
nication with the reference healthcare professionals, and,
consequently, they are able of empowering the patient in the
self-management of the disease condition andhis/her therapy
[29, 30]. A systematic review showed a positive impact
of mHealth on patient engagement in the management of
chronic diseases [31]: diabetic patients who transferred daily
glucose readings to physicians using a telematics system and
received telephone medication regimen feedback improved
their clinical outcomes and presented a better glycemic con-
trol [32]. Likewise, the use of textmessage interventions, such
as reminders and updates through SMS, ensured a greater
adherence to prescription and improved clinical outcomes
[33]. Furthermore, studies confirmed the effectiveness of
mHealth interventions in modifying type 2 diabetes patients
lifestyles, especially those related to dietary behaviors and
physical activity, by facilitating diabetes self-management
processes outside the clinical setting [34–36].
However, mHealth and eHealth interventions in order to
be successful need the clear endorsement from the healthcare
system. Particularly, the reference healthcare professionals
are the key actors, from the patients’ perspective, that can
legitimize the intervention process and can motivate type
2 diabetes patients in being compliant with mHealth and
eHealth [37]. This underlines the role of healthcare organi-
zational and professional cultures in enhancing or inhibiting
the effectiveness of mHealth and eHealth interventions in
managing type 2 diabetes. More attention is needed to
explore how innovation through the introduction of new
health technologies can be integrated in the systems of
symbols, practices, and power relationships already existent
in healthcare organizations [38]. Thus, the enabling role of
healthcare professionals in the eHealth and mHealth inter-
ventions for type 2 diabetes needs to be further considered as
a fundamental ingredient for their clinical success. Health-
care professionals should sustain type 2 diabetes patients’
autonomy in care management and thus their motivation to
adhere to the mHealth and eHealth intervention.
Based on these premises, the present study, carried out
on a sample of Italian type 2 diabetes patients, was aimed at
verifying the following hypotheses:
(1) The perceived ability of the healthcare professionals
to support patients’ autonomy influences the level of
patients’ engagement towards their caremanagement.
(2) The perceived ability of the healthcare professionals
to support patients’ autonomy influences the level of
patients’ activation towards their care management.
(3) The levels of patients engagement mediate the asso-
ciation between the perceived ability of healthcare
professionals to support patients’ autonomy and the
level of patients’ activation.
(4) A higher level of activation is associated with a higher
use of mHealth and eHealth technologies to seek
information for managing type 2 diabetes care.
(5) A higher level of use of mHealth and eHealth tech-
nologies to seek information for managing type 2
diabetes care is associated with a higher patients’
adherence to type 2 diabetes care.
2. Materials and Methods
2.1. Recruitment and Data Collection. This cross-sectional
quantitative study included a sample of 93 Italian-speaking
type 2 diabetes patients and was conducted on the basis of
a structured questionnaire including validated measures (see
Section 2.2) to assess the causal relations among the con-
structs under analysis (see research hypotheses stated above).
Patients were recruited through the online panel provided by
Research Now (http://www.researchnow.com/en-US.aspx).
The panel covers a wide range of chronic conditions and
counts more than 6.5 million registered subjects worldwide.
Subjects belonging to the panel are carefully screened for
authenticity and legitimacy via digital fingerprint and geo-
IP-validation from the provider. All panelists are profiled on
the basis of their sociodemographic, clinical, and lifestyle
characteristics. The panel is certified to be statistically repre-
sentative of all the covered populations. In our study, in order
to guarantee data quality, respondents were asked to confirm
their demographics (i.e., sex, date and place of birth, ethnicity,
nationality, educational level, and place of residency) and
clinical condition previously collected by the panel. To be
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included in our study, patients belonging to the panel had to
be Italian, affected by type 2 diabetes, aged over 18 years, and
of both genders. Patients with dementia, cognitive impair-
ments, active psychiatric disorders, blindness, deafness, or
insufficient Italian language skills to meaningfully answer the
questions or without informed consent were excluded from
this study. All participants gave written informed consent
before being enrolled in the study. Patients completed the
study questionnaire between October and December 2014.
Ethic approval was attained from the Ethics Committee of the
Universita` Cattolica del Sacro Cuore, Milan (Italy).
2.2. Measures. Patient Health Engagement Scale (PHE-S)
developed by Graffigna and colleagues [39] is a measure of
patient engagement that is grounded in rigorous conceptu-
alization and appropriate psychometric methods. The scale
consists of 5 ordinal items and was developed based on
the authors’ conceptual model of patient engagement (PHE-
model), which features four positions along a continuum
of engagement (i.e., blackout; arousal; adhesion; eudaimonic
project).These engagement positions result from the conjoint
cognitive (thinking), emotional (feeling), and conative (act-
ing) enactment of individuals toward their health manage-
ment [15].
Patient Activation Measure (PAM) developed by Hibbard
and colleagues [40], the 13-item Patient Activation Measure,
is an interval-level, unidimensional Guttman-like measure
that contains items measuring self-assessed knowledge about
chronic conditions, beliefs about illness and medical care,
and self-efficacy for self-care. The PAM focused on physical
conditions, and it was designed to measure activation as a
broad construct. In the present study, we used the Italian
validated version of the PAM [41].
Morisky Medication Adherence Scale (MMAS-4). Medica-
tion-taking behavior was assessed using the 4-item Morisky
Medication Adherence Scale. This simple 4-question survey
assesses the likelihood of patients taking their drug therapy
as prescribed. The items measure the degree to which the
patients self-report nonadherence to prescribed medication
due to forgetting, carelessness, stopping the drug when
feeling better or stopping the drug when feeling worse. In
the present study, we used the Italian validated version of the
MMAS-4 [42].
Health Care Climate Questionnaire (HCCQ). This scale
assesses patients’ perceptions of the ability of the health-
care professionals in supporting their autonomy (versus
“controllingness”) and in motivating their initiative in care
management. The HCCQ consists of 15 items on a seven-
point Likert scale ranging from strongly disagree to strongly
agree. The scale was firstly developed and validated on the
diabetic population by Williams and colleagues [43, 44].
Demographic characteristics included age (<60;≥60); gen-
der (male or female); education (elementary school, junior
high school, high school, college education, Ph.D. degree,
or M.S. degree); occupational status (employed, retired,
housewife, student, unemployed, or other); marital status
(never married, married, divorced, or widowed).
Frequency of mHealth/eHealth Use. An ad hoc item was
developed to assess patients’ behaviors concerning the use of
mHealth and eHealth technologies to seek information for
managing type 2 diabetes care (i.e., “I usually use internet or
mobile devices to seek information for managing my care”).
The item has 7 response options on a Likert scale (never,
almost never, occasionally, sometimes, often, almost always,
or always).
2.3. Data Analysis. Data analysis was conducted in four
steps. In the first step of analysis, descriptive analyses were
conducted, with particular reference to sociodemographic
characteristics of the sample. Furthermore, descriptive statis-
tics were provided regarding the use of mHealth and eHealth
technologies to seek information for managing type 2 dia-
betes care.
In the second step of the analysis, the psychometric
properties of the instruments were assessed in terms of
reliability by using Cronbach’s alpha for metric variables or
ordinal alpha via Empirical Copula for ordinal variables [45].
A Cronbach or ordinal alpha higher than 0.7 was considered
acceptable.
In the third step of analysis, correlations between all the
considered variables were calculated. Since every instrument
produces a metric score, the linear correlation coefficient 𝑟
was calculated and evaluated with a significance test.
In the last step, a Structural Equation Model with
observed variables using ML estimation method was imple-
mented [46], in order to evaluate the relationships between
the considered variables and to explore the theoretical
hypothesized model (see the 5 hypotheses stated above). In
themodel we consideredHCCQ as an exogenous variable and
mediator (PHE-S) and dependent variables (PAM, MMAS-4,
and frequency of mHealth/eHealth use) as endogenous vari-
ables. The goodness-of-fit indexes were examined through
Chi square test, RMSEA, CFI, and SRMR, particularly suit-
able for both large and small samples. Models with acceptable
fit presented nonsignificant Chi square value, RMSEA < 0.08
CFI > 0.90 and SRMR < 0.08 [47]. To improve the goodness-
of-fit, modification indices were considered.
2.4. Ethical Concerns. The study received approval from
the Universita` Cattolica del Sacro Cuore Ethics Committee.
Patients consented to participate in the study, and they were
allowed to withdraw from the study whenever they wanted.
The data were collected anonymously and analyzed in an
aggregated way.
3. Results
Overall, 93 patients were invited to participate in the study
and completely answered the questionnaire for the analysis.
All patients (29 females) completed the survey, mean age of
58.3 (±12.4) years with a mean disease duration of almost
11 years. Sociodemographic and psychometric characteris-
tics are summarized in Table 1. Mean, standard deviation
(unless otherwise indicated), and a suitable reliability index
(Cronbach’s alpha or ordinal alpha via Empirical Copula)
are reported for all the psychometric measures considered.
All the psychometric measures presented a good or excellent
4 Journal of Diabetes Research
Table 1: Characteristics of the sample.
Sociodemographic characteristics
Age (years) M = 58.3; DS = 12.4
Gender (% female) 31.2
Disease duration M = 14.4; DS = 11.1
Marital status (%)
Never married 7.5
Married 79.5
Divorced 10.8
Widowed 2.2
Employment (%)
Employed 43.0
Retired 44.0
Housewife 3.2
Student 2.2
Unemployed 5.4
Other 2.2
Education (%)
Elementary school 5.4
Junior high school 14.0
High school 50.5
College education 23.7
Ph.D. or M.S. degree 6.4
Psychometric measures
PHE-S Median = 3 (range 1–4); entropy = 0.89; ordinal alpha = 0.82
PAM M = 66.8 (range 0–100); DS = 18.3; Cronbach’s alpha = 0.93
MMAS-4 M = 1.3 (range 0–4); DS = 1.3; Cronbach’s alpha = 0.81
HCCQ M = 66.8 (range 13–91); DS = 15.1; Cronbach’s alpha = 0.92
Table 2: Frequency of mHealth/eHealth use.
I usually use internet or mobile devices to seek information for
managing my care (%)
Never 14.0
Almost never 5.3
Occasionally 5.3
Sometimes 19.4
Often 17.2
Almost always 19.4
Always 19.4
reliability, with aCronbach’s or ordinal alpha ranged from0.81
to 0.93.
Table 2 reports the distribution of the ad hoc item
(frequency of mHealth/eHealth use), created to assess patients’
behaviors concerning the use of mHealth and eHealth tech-
nologies to seek information for managing type 2 diabetes
care (i.e., “I usually use internet or mobile devices to seek
information for managing my care”). Table 2 shows that much
more than 50% of our sample used regularly (i.e., often, very
often, or always) mHealth or eHealth technologies to seek for
information for managing their type 2 diabetes care. Only
20% of the sample did not regularly use such technologies.
In Table 3 linear correlation coefficients between the
considered psychometric variables are reported.
HCCQ presented a significant correlation with all the
measures: a positive correlation with PHE-S, PAM, and
frequency of mHealth/eHealth use and a negative correla-
tion with MMAS-4 were detected. PHE-S showed a sig-
nificant direct correlation with HCCQ and PAM, while
it had no significant correlation with MMAS-4 and fre-
quency of mHealth/eHealth use. PAM had a significant direct
correlation with all the measures except from MMAS-4:
PAM and MMAS-4 were negatively correlated. Frequency of
mHealth/eHealth use significantly only depended on HCCQ
and PAM.
Considering the five hypotheses to be tested in the study
and the detected correlations between the psychometricmea-
sures and the frequency of mHealth/eHealth use, a Structural
Equation Model was implemented.
Relationships between patients’ perceptions of the ability
of the healthcare professionals in supporting their autonomy
(HCCQ), patients’ engagement (PHE-S), patient’s activation
(PAM), medication adherence (MMAS-4), and the frequency
of mHealth/eHealth use were tested. Figure 1 shows the
explanatory model of the hypotheses we wanted to verify.
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Table 3: Linear correlations coefficients between psychometric measures and frequency of mHealth/eHealth use.
HCCQ PHE-S PAM MMAS-4 mHealth/eHealth
HCCQ — 0.356∗∗ 0.406∗∗ −0.315∗∗ 0.292∗∗
PHE-S — 0.428∗∗ −0.244∗ 0.034
PAM — −0.222∗ 0.373∗∗
MMAS-4 — −0.090
mHealth/eHealth —
∗
𝑝 < 0.05; ∗∗𝑝 < 0.01.
HCCQ PHE-S
PAM
mHealth/
eHealth MMAS-4
−0.04
0.32
∗∗
0.25
∗
0.30
∗∗
0.39
∗∗
Figure 1: Structural Equation Model 1.
HCCQ
PAM
PHE-S
mHealth/
eHealth
MMAS-4
0.30
∗∗
0.30
∗∗
−0.33
∗∗
0.42
∗∗
0.40
∗∗
Figure 2: Structural Equation Model 2.
The model showed an exogenous observed variable
(HCCQ), four endogenous observed variables (PHE-S, PAM,
frequency of mHealth/eHealth use, andMMAS-4).The PHE-S
mediates the relationship between HCCQ and PAM.
The model fit was deemed to be not acceptable (𝜒2(5) =
15.50, 𝑝 < 0.01; CFI = 0.59; RMSEA = 0.15). Almost all the
paths were found to be significant (∗∗𝑝 < 0.01, ∗𝑝 < 0.05),
except the path between frequency of mHealth/eHealth use
andMMAS-4 (−0.04, 𝑝 = 0.74).
The hypotheses were only partially verified. On the basis
of the evaluation of themodification indexes, the correlations,
and the estimated paths, a modification of the model was
hypothesized and tested. In particular modification indexes
suggested to emphasize the direct relationship between
HCCQ and MMAS-4 and to delete the relationship between
frequency of mHealth/eHealth use andMMAS-4. TheMMAS-
4 resulted consequently from a high level of patients’ percep-
tions about the ability of the healthcare system in supporting
their autonomy (HCCQ). The frequency of mHealth/eHealth
use resulting is strongly dependent on the level of patients’
activation (PAM), but it did not seem to impact on patients’
adherence (MMAS-4). Figure 2 shows the final model.
Model 2 presented an acceptable goodness-of-fit. Chi
square test was not significant (𝜒2(5) = 7.54, 𝑝 = 0.15).
All the goodness-of-fit was satisfactory (RMSEA = 0.07,
CFI = 0.90, and SRMR = 0.06). The estimated paths were
significant (𝑝 < 0.001). The adjusted goodness-of-fit (AGFI)
was superior to 0.90 (AGFI = 0.901).Overall,model fit indices
significantly increased fromModel 1 to Model 2.
4. Discussion
This study aimed to verify how the perceived ability of the
healthcare professionals to support type 2 diabetes patients’
autonomy andmotivation to self-care initiative might impact
on their level of activation and engagement and, conse-
quently, on their adoption of mHealth and eHealth technolo-
gies to seek information for managing care. Furthermore,
the study aimed to test the mediating role of patient engage-
ment in the relationship between the healthcare professional
motivating role and patient activation. Finally, the study
explored the impact ofmHealth and eHealth technologies use
for health information seeking on type 2 diabetes patients’
adherence.
Concerning the first two hypotheses, the study confirmed
the crucial role of the healthcare professionals in influencing
the level of type 2 diabetes patients’ engagement and acti-
vation, according to other studies on chronic populations
[17]. Furthermore, the level of type 2 diabetes patients’
activation was confirmed in influencing patients’ adoption of
mHealth/eHealth technologies to support care management
and seek health information [48, 49].
This study showed how the more clinicians are perceived
by patients as able to motivate their initiatives towards self-
care, the more the patients report higher level of engagement
and activation in healthcare processes. Type 2 diabetes
patients’ perception and assessment of the healthcare pro-
fessionals’ ability to be aligned with their needs and expec-
tations toward care management are, thus, demonstrated
to be a crucial antecedent of the patients’ ability to take
an active role in their care management. The more the
healthcare system is perceived as facilitating type 2 diabetes
patients’ autonomy, the more the patients show higher level
of engagement towards their care management. To foster
patients engagement in care management means to support
the complex psychosocial elaboration of the illness condi-
tion and of the new medical requirements that individuals
undergo when diagnosed with type 2 diabetes (and/or when
new symptoms occur) [14, 50]. Consequently, the role of
healthcare professionals appears pivotal in supporting type 2
diabetes patients engagement in adopting healthier lifestyles
and gaining higher quality of life [29, 51].
Furthermore, as this study showed, high level of type
2 diabetes patients engagement is predictive of the patients
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activation in self-management: the more the type 2 diabetes
patient is engaged, the more he/she appears able to feel self-
confident in assuming a proactive and empowered role in the
care process. The huge impact of cognitions and behaviors
is well reported in literature [14, 29]. However, patients’
engagement is the result of a dynamic synergy among dif-
ferent experiential dimensions: patient engagement, indeed,
is not only dependent on knowledge and skills related to the
health condition and treatment management. It also implies
patients’ enactment of an adaptive emotional elaboration and
acceptance of the newpatient identity and of its consequences
on quality of life [14, 22].
The level of type 2 diabetes patients’ activation in its
turn resulted to be a crucial antecedent of patients’ attitude
towards the adoption of mHealth and eHealth technologies
to seek information for caremanagement. Patients’ activation
refers to the patients’ ability and willingness to directly
manage their own health and health care [39]. To seek health
and care information through mHealth and eHealth tech-
nologies to manage care might be considered as a behavioral
manifestation of the patients’ willingness of taking a “starring
role” in the management of their care [50].
Different studies investigated the potential role of
mHealth/eHealth technologies to support patient activation
and used the patient activation as a compass to personalize
the intervention with promising results [35, 52]. In this
sense, our study provides further evidences on a crucial
antecedent of patient activation: that is patient engagement.
This conceptmight be useful when developing and delivering
technological solutions, which are aligned with the complex
emotional elaboration the patient undergoes when dealing
with diabetes care and allow them to communicate with their
referential health professional [53].
Moreover, our results confirmed the importance of ques-
tioning the readiness of the healthcare organization and
of its employees in receiving and adopting technological
innovations devoted to sustaining better integrated models
of care [54, 55]. Implicit values and practices rooted into
the organizational culture might play the role of enhancers
or inhibitors of such organizational innovation. Relational,
psychological, and pragmatic implications of eHealth and
mHealth should be considered when planning and delivering
such interventions in order to maximize their clinical and
organizational effectiveness. Healthcare professionals’ educa-
tion oriented to uncovering of clinicians’ experiential knowl-
edge and attitudes towards patients’ engagement should be a
priority in this changing scenario [56].
Finally, it is interesting to note that the last hypothesis of
this study was not confirmed.The level of patients’ adherence
was not proved to be directly dependent on the frequency
of mHealth and eHealth adoption to seek information for
type 2 diabetes care management, thus demonstrating that
this is still a controversial topic according to other studies
[57]. In this sense, spontaneous behaviors of information
seeking through mHealth and eHealth sources are not an
indication of greater patients’ adherence. Health information
obtained through online sources has been widely debated
for their inaccurate and misleading nature which can lead
to ineffective self-care regimens if not properly sustained
by healthcare professionals [58]. Furthermore, the ability
of mHealth or eHealth to foster type 2 diabetes patients’
adherence might be dependent on the characteristics of the
intervention and of the specific tools employed in it; mHealth
and eHealth tools for information seeking probably need
tailored and multiple strategies to promote adherence [57].
Patients’ adherence resulted, on the contrary, from direct
function of the healthcare professionals’ perceived ability to
support patients’ autonomy and motivation towards their
diabetes care. This result appears particularly interesting
because it is a further empirical confirmation of the crucial
role played by the healthcare organization and by its employ-
ees to enable the success of clinical interventions. Indeed,
healthcare professionals seem to have a vicarious role in the
proper use of health information and in the activation of
patients towards managing their health and, consequently,
in patients’ adherence. Different studies confirmed that the
quality of the relationship between healthcare professionals
and patients is a crucial factor for improving the adherence
of patients [59, 60]. Our results suggest the importance of
supporting the introduction of new technological tools to
innovate healthcare processes with a deep understanding of
the psychosocial, relational, and pragmatic implication of
such innovation: only “taking on board” the human resources
implied in this organizational change, the challenge of inno-
vating care process in an effective integrated model can be
successful [61, 62]. Healthcare professionals, in particular,
need to be accompanied to understand and accept the value
of such tools to improve their ability to follow and treat
their type 2 diabetes patients. Healthcare professionals are
the enablers, from patients’ perspective, of the mHealth or
eHealth interventions’ clinical potentials; they are perceived
as the legitimators of the active role of the patient in the
care process [17] and thus of the possibility to adopt new
technologies within the type 2 diabetes care pathway within
a shared decision making process [63].
Therefore, mHealth or eHealth initiatives for type 2
diabetes care should be designed and delivered having in
mind the goal of sustaining the engagement of the dif-
ferent stakeholders implied in the healthcare process (i.e.,
the patients, their lay caregivers but also their healthcare
professionals both inside and outside the hospital) [11, 14, 38].
This goal could be achieved by assuming a psychosocial and
organizational view of the different level of needs and expec-
tations towards the care process (and its innovation) carried
out by the different stakeholders: to fail in this consideration
may result in psychosocial and relational hindrances to the
process of adoption of mHealth or eHealth and thus to their
clinical effectiveness. This could also have an impact on the
success of integrated care models featuring the adoption of
new technologies [12].
Limitations. Although the results of our study appear interest-
ing to cast light on the complex psychosocial and organiza-
tional dimensions implied in sustaining patient engagement
and the adoption of mHealth or eHealth for seeking infor-
mation for type 2 diabetes care in integrated care models,
some limitations have to be considered. Firstly, the study
was carried out on a fairly small sample of Italian patients.
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However the sample features were enough to allow the
robustness of the conducted statistical analysis. Furthermore,
the sample of patients included in our study is not repre-
sentative of the Italian type 2 diabetes population. However,
we used it only to explore the relationships of the variables
under analysis and not for an estimation of their dimen-
sions: based on these considerations full representativeness
is not necessarily required [64, 65]. Furthermore, our study
was not conceived as an effectiveness evaluation of a real
mHealth or eHealth intervention, but it took into account the
spontaneous behaviors of patients when adoptingmHealth or
eHealth technologies to seek information for type 2 diabetes
care management. This may be envisaged as a limitation
because it does not allow the researcher to understand what
technological and organizational characteristic of a mHealth
or eHealth intervention may impact on patients’ engagement
and activation and on their adherence to treatment. Results
should be interpreted with caution because of the explorative
nature of this study. Furthermore, we only measured the
frequency of spontaneous behaviors of mHealth and eHealth
use to seek information for diabetes care instead ofmeasuring
also type of technologies adopted or type of information
searched.
However, this analysis has the value of offering some
precious insights into the patients’ spontaneous attitudes and
behaviors in a natural setting and should be considered as
a “baseline” evidence of the general approach of patients to
mHealth or eHealth and of the psychosocial and organiza-
tional dynamics that may impact on their effectiveness [66].
5. Conclusions
Type 2 diabetes requires a long-term approach to care and the
good synergy between hospitals and primary care resources.
To address this requirement, to “give back” an active role to
patients inmanaging their health is crucial. mHealth/eHealth
interventions for type 2 diabetes care are considered as an
effective strategy to improve type 2 patients’ empowerment
and clinical outcomes. Moreover they are demenstrated to
be powerful in enhancing patients-doctors communication,
in fostering patients’ satisfaction with care and in making
healthcare cost-effective. However, in order to be effective,
the introduction of such technological interventions needs
to be supported by the reference healthcare professionals,
who should legitimize the intervention process and sustain
the autonomous initiative of the type 2 diabetes patients
throughout it.
From this perspective, our study confirmed the important
role of healthcare professionals’ ability to foster type 2
diabetes patients’ autonomy in enhancing their activation and
engagement towards self-management, this being a precursor
of patients’ attitude to the use of mHealth/eHealth technolo-
gies. Furthermore, our study well highlighted how patient
engagement, defined as a multidimensional psychosocial
process resulting from the conjoint cognitive, emotional,
and behavioral enactment of individuals toward their health
conditions and their management [15, 17, 38], is a pivotal
precursor of patient activation towards self-management and
thus towards patients’ use of new technological interven-
tions. This finding is relevant and opens insights into the
psychosocial and relational antecedent of patients’ activation
in self-management. The function of patients’ activation in
guaranteeing improved clinical outcomes, better patients’
satisfaction towards healthcare, and reduced costs in services
delivery has been demonstrated by several studies [67–69].
However, till now, still little is known about the factors
that may support the increase of patients’ activation [70].
This study, by focusing on type 2 diabetes patients, offers
an important theoretical and pragmatic contribution by
demonstrating the role of patient engagement in determining
the level of patients’ behavioral activation and self-confidence
in type 2 diabetes care management.
Finally, the indirect relationship that our study showed
between the frequency of mHealth/eHealth use and the level
of type 2 diabetes patients’ adherence, although it needs
further confirmation, opens the door to interesting debate
about how new technologies can be effectively designed in
order to improve adherence. Too often, the debate about
new mHealth/eHealth interventions for sustaining patient
engagement in type 2 diabetes care management has been
primarily focused on the technological (“hard”) features of
such interventions [71]. The psychosocial and organizational
(“soft”) aspects may mediate the effectiveness of mHealth
and eHealth interventions and, consequently, deserve an
enhanced attention, as an important complement of the
analysis of the “hard” determinants of such interventions
effectiveness [72].
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